<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pulmo</journal-id><journal-title-group><journal-title xml:lang="ru">Пульмонология</journal-title><trans-title-group xml:lang="en"><trans-title>PULMONOLOGIYA</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0869-0189</issn><issn pub-type="epub">2541-9617</issn><publisher><publisher-name>Scientific and Practical Journal “PULMONOLOGIYA” LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">pulmo-3829</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИКО-ЭКСПЕРИМЕНТАЛЬНОЕ ИЗУЧЕНИЕ МАКСАКВИНA  В РОССИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL AND EXPERIMENTAL STUDIES MAXAGUIN IN RUSSIA</subject></subj-group></article-categories><title-group><article-title>Химиотерапевтическая активность Максаквина in vivo на моделях острых бактериальных и нфекций в опытах на мышах</article-title><trans-title-group xml:lang="en"><trans-title>Chemotherapeutic activity of Maxaquin invivo in models of acute bacterial infections in mice</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Падейская</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Padeyskaya</surname><given-names>E. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шипплова</surname><given-names>Л. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Shipilova</surname><given-names>L. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Миацакапян</surname><given-names>В. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Mnatzakanyan</surname><given-names>V. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Центр по химии лекарственных средств — Всероссийский научно-исследовательский химико-фармацевтический институт (ЦХЛС—ВНИХФИ)</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>1993</year></pub-date><pub-date pub-type="epub"><day>27</day><month>04</month><year>2022</year></pub-date><volume>0</volume><issue>0</issue><issue-title>Приложение</issue-title><fpage>63</fpage><lpage>67</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Падейская Е.Н., Шипплова Л.Д., Миацакапян В.Э., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Падейская Е.Н., Шипплова Л.Д., Миацакапян В.Э.</copyright-holder><copyright-holder xml:lang="en">Padeyskaya E.N., Shipilova L.D., Mnatzakanyan V.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.pulmonology.ru/pulm/article/view/3829">https://journal.pulmonology.ru/pulm/article/view/3829</self-uri><abstract><p>.</p></abstract><trans-abstract xml:lang="en"><p>.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Г'лушков Р.Г., Левшич И.Б., Марченко II.Б., Падейская Е Л . Антибактериальные препараты группы хиполои -карбоповой кислоты / / Хим .-фарм .жури .— 1989.— N 9 — С 1048 __ 1064.</mixed-citation><mixed-citation xml:lang="en">Г'лушков Р.Г., Левшич И.Б., Марченко II.Б., Падейская Е Л . Антибактериальные препараты группы хиполои -карбоповой кислоты / / Хим .-фарм .жури .— 1989.— N 9 — С 1048 __ 1064.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Падейская E.II. Методы экспериментальной химиотерапии и бактериальных инфекций / / Методы экспериментальной химиотерапии / Под ред. Г .И .Першипа — М.: Медицина 1971.— С .106— 143.</mixed-citation><mixed-citation xml:lang="en">Падейская E.II. Методы экспериментальной химиотерапии и бактериальных инфекций / / Методы экспериментальной химиотерапии / Под ред. Г .И .Першипа — М.: Медицина 1971.— С .106— 143.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Падейская E.II. Фтор -хинолоны и их значение в современной химиотерапии и инфекционных заболеваний / / Антибиотик и .— 1989.— N 7 .— С .5 1 4 — 521.</mixed-citation><mixed-citation xml:lang="en">Падейская E.II. Фтор -хинолоны и их значение в современной химиотерапии и инфекционных заболеваний / / Антибиотик и .— 1989.— N 7 .— С .5 1 4 — 521.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Яковлев Б.Г. Антибактериальная химиотерапия в неифекционной клинике / / Итоги науки и техники . Фармакология , химио-терапевтические средства.— М ., 1992.— т .2 0 .— С .З — 201.</mixed-citation><mixed-citation xml:lang="en">Яковлев Б.Г. Антибактериальная химиотерапия в неифекционной клинике / / Итоги науки и техники . Фармакология , химио-терапевтические средства.— М ., 1992.— т .2 0 .— С .З — 201.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Barry A.L. in vitro activity of the quinolones and related compounds / / The New Generation of Q uinolones / Eds. C .Siporin , C .L .IIeifetz, J.M .D o rn ag al.— New York, 1990 __ P .7 9 — 107.</mixed-citation><mixed-citation xml:lang="en">Barry A.L. in vitro activity of the quinolones and related compounds / / The New Generation of Q uinolones / Eds. C .Siporin , C .L .IIeifetz, J.M .D o rn ag al.— New York, 1990 __ P .7 9 — 107.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chin N .X., N ovelli A., Neu H.С. In vitro activity of lom cfloxacin (S C -47111 , N Y -198), a difluoroquinolone 3 -carboxylic acid, compared with those of other quinolones / / Antimicrob .Agents Chcmothcr.— 1988.— V ol.3 2 .— P .6 5 6 — 662.</mixed-citation><mixed-citation xml:lang="en">Chin N .X., N ovelli A., Neu H.С. In vitro activity of lom cfloxacin (S C -47111 , N Y -198), a difluoroquinolone 3 -carboxylic acid, compared with those of other quinolones / / Antimicrob .Agents Chcmothcr.— 1988.— V ol.3 2 .— P .6 5 6 — 662.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Fenlandes P. В., Swanson R.N. Correlation of in vitro activities o f fluoroquinolones to their in vivo ef ficacies / / Drugs. Exp. Clin .R es.— 1 9 8 8 .— V ol. 14.— P .3 7 5 — 378.</mixed-citation><mixed-citation xml:lang="en">Fenlandes P. В., Swanson R.N. Correlation of in vitro activities o f fluoroquinolones to their in vivo ef ficacies / / Drugs. Exp. Clin .R es.— 1 9 8 8 .— V ol. 14.— P .3 7 5 — 378.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">H¡rose / ., Okezaki E., Kalo H. ct al. In vitro and in vivo activity of N Y -198, a new difluorinatcd quinolone / / Antimicrob .Agents Chcmothcr.— 1987.— Vol.3 1 .— p . 854 — 859.</mixed-citation><mixed-citation xml:lang="en">H¡rose / ., Okezaki E., Kalo H. ct al. In vitro and in vivo activity of N Y -198, a new difluorinatcd quinolone / / Antimicrob .Agents Chcmothcr.— 1987.— Vol.3 1 .— p . 854 — 859.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Neu II.С. The quinolones: prosp ects / / The Q uinolones /Ed . V .T .Addriole.— London: Academic Press, 1988 .— P .235 — 254.</mixed-citation><mixed-citation xml:lang="en">Neu II.С. The quinolones: prosp ects / / The Q uinolones /Ed . V .T .Addriole.— London: Academic Press, 1988 .— P .235 — 254.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sinior A .E ., Fuller S.A., Low D.E. Comparative in vitro activities of Sparfloxacin (C I-978, A T -4140 ) and other antimicrobial agents against Staphylococci, Euterococci and respiratory tract pathogens / / Antimicrob .Agents Chcmothcr .— 1990 — V ol.3 4 .— P .2283 — 2286.</mixed-citation><mixed-citation xml:lang="en">Sinior A .E ., Fuller S.A., Low D.E. Comparative in vitro activities of Sparfloxacin (C I-978, A T -4140 ) and other antimicrobial agents against Staphylococci, Euterococci and respiratory tract pathogens / / Antimicrob .Agents Chcmothcr .— 1990 — V ol.3 4 .— P .2283 — 2286.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Siropin C. The evaluation of fluorinated quinolones : pharmacology, microbiology activity, clinical uses and toxicities / / Ann.Rev.Microbiol.— 1989.— Vol.4 3 .— P .6 0 1 — 627.</mixed-citation><mixed-citation xml:lang="en">Siropin C. The evaluation of fluorinated quinolones : pharmacology, microbiology activity, clinical uses and toxicities / / Ann.Rev.Microbiol.— 1989.— Vol.4 3 .— P .6 0 1 — 627.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Waclworlh A .N ., Goa K.L. Lomcfloxacin . A review of its antibacterial activity, pharmacokinetic properties and therapeuticuse / / Drugs.— 1991 .— V ol.4 2 .— P . 1018— 1060.</mixed-citation><mixed-citation xml:lang="en">Waclworlh A .N ., Goa K.L. Lomcfloxacin . A review of its antibacterial activity, pharmacokinetic properties and therapeuticuse / / Drugs.— 1991 .— V ol.4 2 .— P . 1018— 1060.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
